Evidence map›Paper›PMID 30644363›Full record

ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2019

The role of Blastocystis hominis in the activation of ulcerative colitis.

Mehmet Kök, Yeşim Çekin, Ayhan Hilmi Çekin, Seyit Uyar, Ferda Harmandar, Yasin Şahintürk

Open access · greenAbstract read
In one paragraph

Article in The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Lower prevalence of Blastocystis spp. and Dientamoeba fragilis in ulcerative colitis and association with disease activity.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Pathogens (Basel, Switzerland) · 2025
    Article
  4. The Role ofPathogens (Basel, Switzerland) · 2025
    Review
  5. Blastocystis hominis; Friend or Foe.Integrative medicine (Encinitas, Calif.) · 2024
    Review
  6. Integrated Omics Reveal the Pathogenic Potential ofTransboundary and emerging diseases · 2024
    Article
  7. Article
  8. Article
  9. Influence ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  10. Article
  11. Blastocystis and Clostridioides difficile: Evidence for a Synergistic Role in Colonization Among IBD Patients with Emphasis on Ulcerative Colitis.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2021
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Parasite-bacteria interrelationship.Parasitology research · 2020
    Review
  17. Review
  18. Molecular Epidemiology and Risk Factors ofRisk management and healthcare policy · 2020
    Article
  19. Anti-International journal of environmental research and public health · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Mehmet KökDepartment of Internal Medicine, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey.
Yeşim ÇekinDepartment of Microbiology, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey.
Ayhan Hilmi ÇekinDepartment of Gastroenterology, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey.
Seyit UyarDepartment of Internal Medicine, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey.
Ferda HarmandarDepartment of Gastroenterology, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey.
Yasin ŞahintürkDepartment of Internal Medicine, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey.
Antalya Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsSeveral studies have shown that a change in microbiota plays an important role in the pathogenesis of inflammatory bowel disease (IBD). Furthermore, with the emergence in recent studies of differences according to the subtype of IBD and whether the disease is active or in remission, there has started to be research into the relationship between IBD and several microorganisms. Blastocystis hominis is primary among these organisms. The aim of the present study was to determine the role of B. hominis in the acute flare-up of ulcerative colitis (UC). MATERIALS AND

methodsA total of 114 patients with UC were included in the study, with 52 in the active phase. The Mayo scoring system was used for the activity index. Patients determined with a flare-up agent other than B. hominis were excluded from the study. Fecal samples of the patients were examined by the polymerase chain reaction method for the presence of B. hominis.

resultsB. hominis positivity was determined in 37 (34%) patients with UC. Of the patients, 17 (32.6%) were in the acute flare-up phase, and 20 (32.2%) were in remission (p=0.961). In 11 (64.7%) of the B. hominis positive patients, the disease severity was determined as mild-moderate (p<0.001).

conclusionThe results of the present study showed that while there was no difference between the active and remission phases in respect of B. hominis presence, there was milder involvement in those determined with B. hominis.

Indexed as

Blastocystis hominisSymptom Flare UpAdultBlastocystis InfectionsColitis, UlcerativeFecesFemaleHumansMaleMiddle AgedRemission Induction

Identifiers

PMID30644363
PMCPMC6389295
OpenAlexW2905480973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.